Pan-cancer proteogenomics characterization of tumor immunity

Keyphrases

• Cancer Cases 50%
• Cancer Treatment 50%
• Cell Composition 50%
• Combination Immunotherapy 50%
• Combination Therapy 50%
• CPTAC 50%
• Durable Response 50%
• Epigenetic Modification 50%
• Genomic Changes 50%
• Immune Cells 50%
• Immune Checkpoint Blockade 50%
• Immune Escape 50%
• Immune Evasion 50%
• Immune Landscape 50%
• Immune Parameters 100%
• Immunotherapy Strategy 50%
• In Cancer 50%
• Integrated Learning 50%
• Kinase Activity 50%
• Pan-cancer 100%
• Pathway Activity 50%
• Phosphoproteomics 50%
• Precision Targeting 50%
• Proteogenomics 100%
• Proteomic Changes 50%
• Subtype-specific 50%
• Therapeutic Target 50%
• Transcriptomic Changes 50%
• Tumor 50%
• Tumor Immunity 100%
• Tumor Tissue 50%

Biochemistry, Genetics and Molecular Biology

• Epigenetics 50%
• Immune Checkpoints 50%
• Immune Evasion 100%
• Immunocompetent Cell 50%
• Kinase 50%
• Phosphoproteomics 50%
• Phosphotransferase 50%
• Proteogenomics 100%
• Proteomics 50%
• Transcriptomics 50%
• Tumor Immunity 100%

Immunology and Microbiology

• Epigenetics 33%
• Immune Checkpoint Blockade 33%
• Immune Evasion 66%
• Immune Landscape 33%
• Immunocompetent Cell 33%
• Immunotherapy 100%
• Transcriptomics 33%
• Tumor Immunity 100%